Submit a manuscript Sign up for article alerts Contact us Support

About Journal of Nanobiotechnology

This page includes information about the aims and scope of Journal of Nanobiotechnology, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

Journal of Nanobiotechnology is an open access, peer-reviewed, online journal communicating scientific and technological advances in the fields of medicine and biology, with an emphasis in their interface with nanoscale sciences. The journal provides biomedical scientists and the international biotechnology business community with the latest developments in the growing field of Nanobiotechnology.

Journal of Nanobiotechnology considers manuscripts in the following areas:

Nanoscale applications in biology and medicine:

  • Nanotechnologies for biology and medicine.
  • Micro- and nano- fluidics.
  • Scanning probe microscopy in biology and medicine.
  • Nano-mechanics, biological microelectromechanical and nanoelectromechanical systems (Bio-MEMS and Bio-NEMS).
  • Self-assembly of biological molecules.
  • Structure and dynamics of surfaces and thin films of biological and bioorganic, bioinorganic hybrid materials.

Molecular recognition:

  • Quantitation of molecular interactions.
  • Technologies for detection and analysis of individual biological molecules.

Biological assays:

  • High throughput biological assays and their miniaturization.
  • Lab-on-a-chip assay development.
  • Arrays of biological molecules.
  • Biosensors based on nanomaterials and nanoscale devices.

Materials:

  • Novel materials for biomedical applications.
  • New nanomaterial carriers for drug delivery.
  • Biocompatibility of materials.
  • Molecular engineering.
  • Toxicity and biosafety of nanomaterials.
  • Nanoscale hybrid materials for drug delivery applications.

Bio-imaging Techniques:

  • Biomedical imaging: whole-body and cellular level approaches.
  • The investigation of the behavior of single molecules and nanostructures, with an emphasis on medical, biological and materials science applications.
  • Single molecule imaging and nanoscale characterization and manipulation tools.
  • Subcellular imaging.
  • Nanotechnology and development of next generation nanoscale imaging probes and instrumentation.
  • MRI and NMR imaging using nanoscale contrast agents.
  • The development of new nanoscale-based contrast agents for bioimaging and disease diagnosis.

Open access

All articles published by Journal of Nanobiotechnology are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

Authors of articles published in Journal of Nanobiotechnology are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

Open access publishing is not without costs. Journal of Nanobiotechnology therefore levies an article-processing charge of £1325/$2075/€1690 for each article accepted for publication. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.

Indexing services

All articles published in Journal of Nanobiotechnology are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Journal of Nanobiotechnology include:

  • Biological Abstracts
  • BIOSIS
  • CABI
  • CAS
  • Citebase
  • Compedex
  • DOAJ
  • Embase
  • EmBiology
  • Global Health
  • Google Scholar
  • Index Copernicus
  • MEDLINE
  • OAIster
  • PubMed
  • PubMed Central
  • Science Citation Index Expanded
  • SCImago
  • Scopus
  • SOCOLAR
  • Zetoc

The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).

The full text of all research articles published by BioMed Central is also available on SpringerLink.

Journal of Nanobiotechnology is tracked by Thomson Reuters (ISI) and has an Impact Factor of 4.08.

Publication and peer review process

Content overview

Journal of Nanobiotechnologyconsiders the following types of articles:

  • Research - reports of data from original research.
  • Reviews - summaries of recent insights in specific research areas within the scope of Journal of Nanobiotechnology. These articles are usually commissioned by the Editor but readers are welcome to submit proposals to the Editor-in-Chief.
  • Short communications - these articles are intended for brief reports of findings.

Criteria for publication

  • Peer review in Journal of Nanobiotechnology is designed to ensure that the research published is 'good science'. The journal will consider manuscripts in the fields described above, as long as the results and conclusions are scientifically justified and not misleading.
  • We recognize the importance of highlighting articles that contain the most interesting, important or significant research. Peer reviewers are asked to indicate articles they consider to be especially interesting or significant. These articles will be given greater prominence within Journal of Nanobiotechnology and greater external publicity.
  • Manuscripts submitted to the journal will generally be reviewed by two external experts. Peer reviewers will have four possible options: (i) accept without revision (ii) accept after revision without expecting to check those revisions (iii) neither accept nor reject until author(s) make revisions and resubmit (iv) reject because scientifically unsound.
  • In deciding whether to accept or reject a manuscript, a reviewer asks him/herself whether the scientific community is better served by publishing or not publishing the manuscript. The suitability of a research article for publication in Journal of Nanobiotechnology is assessed by peer reviewers, who base their decision primarily on the article's validity and coherence but who also consider its comprehensibility and level of interest to the reader.
  • When asking for revisions, reviewers have two possible goals: to ask authors to tighten their arguments based on existing data or to identify areas where more data are needed. Reviewers are also asked to say if the manuscript is not sufficiently clearly written for publication. In such cases authors are asked to revise the manuscript, seeking, if necessary, the assistance of colleagues or a commercial editing service.
  • Journal of Nanobiotechnology normally allows authors a maximum of two revisions of a manuscript. The journal will aim to publish research as quickly as possible. The electronic submission process is designed to facilitate rapid publication.

Edited by Fernando Patolsky and Ueli Aebi, Journal of Nanobiotechnology is supported by an expert Editorial Board.

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Journal of Nanobiotechnology, a personalized section of the site.

Reprints

High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.

Supplements

Journal of Nanobiotechnology will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.

Editorial policies

All manuscripts submitted to JN should adhere to BioMed Central's editorial policies.

Citing articles in Journal of Nanobiotechnology

Articles in Journal of Nanobiotechnology should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. J Nanobiotechnol [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. J Nanobiotechnol 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in Journal of Nanobiotechnology?

High visibility

Journal of Nanobiotechnology's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

Journal of Nanobiotechnology offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Journal of Nanobiotechnology, BioMed Central and PubMed Central and will also be included in PubMed.

Flexibility

Online publication in Journal of Nanobiotechnology gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Journal of Nanobiotechnology are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Journal of Nanobiotechnology's pages and on the BioMed Central homepage.

In addition, articles published in Journal of Nanobiotechnology may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Journal of Nanobiotechnology. A list of articles recently press-released by journals published by BioMed Central is available here.

Authors of articles published in Journal of Nanobiotechnology retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright policy and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.